Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 6373 matches for

An internationally recognised centre of excellence for biomedical and clinical research and teaching

Professor Rose McGready recognised for transformative work to improve healthcare for Thai-Myanmar border communities

Professor Rose McGready, Deputy Director of the Shoklo Malaria Research Unit (SMRU), part of the MORU Tropical Health Network within Oxford’s Nuffield Department of Medicine, has been honoured with the 2026 Australian Capital Territory (ACT) Australian of the Year Award.

Women in Clinical Neurosciences (WICN) event reflects on pilot mentorship programme

An exciting research culture event on 17 October 2025 highlighted an ongoing pilot mentorship programme in the department, developed and led by the WICN group.

New study investigates cause of repetitive negative thoughts

Repetitive negative thoughts will be investigated using a range of cutting-edge brain science techniques as part of a new study led by the University of Oxford and funded by Wellcome.

Sir Paul Nurse officially opens the Life and Mind building

The Life and Mind building, a £200 million world-class teaching and research facility, has been officially opened by Sir Paul Nurse, Principal Group Leader, The Francis Crick Institute, President Elect of the Royal Society, and 2001 Nobel Laureate in Physiology or Medicine.

Both total and partial knee replacements deliver lasting benefits at 10 years

New research from a randomised clinical trial provides the strongest long-term evidence yet comparing partial (PKR) and total (TKR) knee replacements for patients with osteoarthritis. Published in The Lancet Rheumatology, the study shows both PKR and TKR being equally effective and offering similar clinical outcomes.

Shared learning in cancer research: Brazilian health leaders visit Oxford

Professor Tim Elliott and colleagues from Oxford Cancer and the Centre for Immuno-Oncology welcomed the Brazilian Minister of Health and senior officials for an official visit organised by the British Embassy in Brazil. The delegation met to exchange insights on cancer research, regulation, and public health, with discussions focusing on prevention, early diagnosis, and innovative treatments such as mRNA vaccines and immunotherapy.

Early diagnosis saves lives: New study highlights critical window for postpartum haemorrhage care

A new international study co-led by Professor Arri Coomarasamy of the University of Birmingham and the Nuffield Department of Women’s and Reproductive Health, University of Oxford, has shown that diagnosing postpartum haemorrhage (PPH) within the first 90 minutes after childbirth can be crucial in preventing maternal deaths.

Oxford and GSK launch Experimental Medicine Collaboration

GSK invests £10 million over five years to establish the Experimental Medicine Collaboration with the University of Oxford.

Two Oxford academics receive ERC Synergy Grants to tackle major scientific challenges

Two Oxford University academics are to co-lead ambitious new research projects backed by European Research Council (ERC) Synergy Grants, part of the EU’s Horizon Europe research and innovation programme. Synergy Grants foster collaboration between outstanding researchers, enabling them to combine their expertise, knowledge and resources to push the boundaries of scientific discovery.

World’s first lung cancer prevention vaccine gets £2 million for clinical trial

People at high risk of lung cancer will soon be able to receive the first-ever experimental vaccine, 'LungVax', designed to prevent the disease, in a world-first clinical trial. The LungVax vaccine carries a series of genetic instructions which train the immune system to recognise tumour antigens on the surface of abnormal lung cells.

Study reveals how drug resistance develops early in targeted AML therapy

A new study led by researchers at the MRC Molecular Haematology Unit has shown that resistance to a targeted treatment for acute myeloid leukaemia (AML) can develop much earlier than expected.

Shaping immunity - the secrets behind the shape of neutrophils

Researchers at the Kennedy Institute have provided the most comprehensive overview to date of how the distinctive segmented nucleus of neutrophils influences their function in health and disease.

Tobacco deaths: the past 75 and the next 75, a guest lecture with Professor Sir Richard Peto

Leading researchers from the Nuffield Department of Primary Care Health Sciences and Nuffield Department of Population Health came together this week for a special event highlighting the enduring impact of research into tobacco addiction and public health.

2025 Teaching Excellence Awards

The Teaching Excellence Awards recognise and reward excellence in teaching, supervision, the organisation and development of teaching, and support for teaching and learning, within a research-intensive environment.

Oxford researchers awarded funding to pioneer ovarian cancer vaccine development

Ovarian cancer remains a devastating global health challenge: each year, over 300,000 women are diagnosed, and nearly 200,000 lives are lost, largely because the disease is detected at a late stage. Women carrying inherited genetic changes face a significantly elevated lifetime risk, over 40%, and current preventive strategies often require invasive surgery that compromises fertility. These limitations underscore an urgent need for non-surgical preventive options, and vaccines could offer a groundbreaking solution.

Bodleian Libraries Update - November 2025 - Global Health Archive | Covidence | Information Skills Courses

Iron supplement absorption preserved in children with HIV and boosted by prebiotics

New research shows that iron from supplements and fortified foods is well-absorbed in children living with virally suppressed HIV, and that administering iron supplements with prebiotics may enhance their effectiveness and improve their safety.

Oxford scientists map the cells that drive Crohn’s disease fistulas

Researchers at the MRC Translational Immune Discovery Unit have identified how rare populations of abnormal cells drive the formation and persistence of fistulas - painful, tunnel-like tracts that develop in around 30% of people with Crohn’s disease - paving the way for targeted treatments.

Hippocampus helps us learn to navigate unknown environments

A new study published in Nature Communications reveals how the hippocampus — a brain region crucial for memory and navigation — supports flexible learning when sensory information is uncertain or incomplete.

Oxford joins £15.9m national initiative to transform cancer research using live human tissue models

Oxford scientists are part of a new £15.9 million UK initiative to transform disease research through the development of advanced human tissue models. The INTREPID project will evaluate and optimise the use of live human tumour samples to enhance the accuracy of preclinical research, speed up drug discovery, and reduce dependence on animal testing.

Load More